You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
When Oregon State Health and Science University researchers led by Shoukhrat Mitalipov reported last year that they had used the gene-editing tool CRISPR/Cas9 to correct a heart disease mutation in viable human embryos, critics were skeptical.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine.
The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.
The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.
In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.